⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22650371 | 0.82 | HPGD (0.32) | — | |
| SCHEMBL18849130 | 0.67 | PIK3CD (0.32) | — | |
| SCHEMBL23059521 | 0.66 | — | — | |
| SCHEMBL21030404 | 0.66 | HPGD (0.40) | — | |
| SCHEMBL20012690 | 0.66 | HPGD (0.40) | — | |
| SCHEMBL6646897 | 0.65 | KMT2A (0.38) | — | |
| SCHEMBL19062637 | 0.65 | PDE4A (0.31) | — | |
| SCHEMBL18499439 | 0.64 | PIK3CD (0.36) | — | |
| SCHEMBL27607442 | 0.64 | TSHR (0.36) | — | |
| SCHEMBL21414317 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354359-A1 | INHIBITING (ALPHA-V)(BETA-6) INTEGRIN | MORPHIC THERAPEUTIC, INC. | 2020-11-12 | — | — | US | disclosed |